Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riikonen

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Medical and Pediatric Oncology|December 18, 2001
Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional studyJ Kanerva, T Niini, K Vettenranta, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 25, 2016
Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in FinlandK Vepsäläinen, R Lassila, M Arola, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 2, 2018
Long-term clinical and economic outcomes in previously untreated paediatric patients with severe haemophilia A: A nationwide real-world study with 700 person-yearsK Vepsäläinen, P Riikonen, R Lassila, et al.
Pediatric Hematology and Oncology|March 24, 1998
Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALLJ Kanerva, M Tiirikainen, A Mäkipernaa, et al.
Haematologica|November 27, 1998
DNA copy number changes in childhood acute lymphoblastic leukemiaM L Larramendy, T Huhta, K Heinonen, et al.
Pediatric Hematology and Oncology|February 24, 2001
Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-upJ Kanerva, M I Tiirikainen, A Mäkipernaa, et al.
European Journal of Pediatrics|January 7, 1999
Recommendations on the use of colony-stimulating factors in children: conclusions of a European panelG Schaison, O B Eden, G Henze, et al.
European Journal of Immunology|December 18, 2001
Both normal and leukemic B lymphocytes express multiple isoforms of the human Aiolos geneJ Liippo, K P Nera, E Veistinen, et al.
Nucleic Acids Research|February 21, 1998
BTKbase, mutation database for X-linked agammaglobulinemia (XLA)M Vihinen, O Brandau, L J Brandén, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Medical and Pediatric Oncology|December 18, 2001
Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional studyJ Kanerva, T Niini, K Vettenranta, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 25, 2016
Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in FinlandK Vepsäläinen, R Lassila, M Arola, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 2, 2018
Long-term clinical and economic outcomes in previously untreated paediatric patients with severe haemophilia A: A nationwide real-world study with 700 person-yearsK Vepsäläinen, P Riikonen, R Lassila, et al.
Pediatric Hematology and Oncology|March 24, 1998
Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALLJ Kanerva, M Tiirikainen, A Mäkipernaa, et al.
Haematologica|November 27, 1998
DNA copy number changes in childhood acute lymphoblastic leukemiaM L Larramendy, T Huhta, K Heinonen, et al.
Pediatric Hematology and Oncology|February 24, 2001
Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-upJ Kanerva, M I Tiirikainen, A Mäkipernaa, et al.
European Journal of Pediatrics|January 7, 1999
Recommendations on the use of colony-stimulating factors in children: conclusions of a European panelG Schaison, O B Eden, G Henze, et al.
European Journal of Immunology|December 18, 2001
Both normal and leukemic B lymphocytes express multiple isoforms of the human Aiolos geneJ Liippo, K P Nera, E Veistinen, et al.
Nucleic Acids Research|February 21, 1998
BTKbase, mutation database for X-linked agammaglobulinemia (XLA)M Vihinen, O Brandau, L J Brandén, et al.
Pageof 6